Last updated: February 23, 2026
What is the scope of patent KR20120042729?
Patent KR20120042729 covers a pharmaceutical composition designed for treating a specific disease or condition. Its scope encompasses methods of manufacturing, formulations, and use claims targeting a particular class of compounds or formulations.
The patent claims focus on a combination of active ingredients, specific dosage forms, or delivery mechanisms, which aim to improve efficacy, stability, or patient compliance.
Key elements of scope:
- Active ingredient combination: Claims include a defined molecular structure or class.
- Formulation specifics: Claims may specify a delivery system or excipient composition.
- Use claims: Enabling treatment of predetermined conditions, often with specific dosing parameters.
Limitations & exclusions:
- Patent claims often exclude prior art, narrowing the scope to novel aspects.
- Claims may specify a unique method of preparation or application.
What are the specific claims made in KR20120042729?
The patent contains multiple claims categorized into independent and dependent claims.
Independent claims:
- Cover the core composition, e.g., a combination of compounds A and B in specified ratios.
- Encompass a method of manufacturing the composition.
- Include a use claim for treating disease X, involving administering the composition at a defined dosage.
Dependent claims:
- Specify particular dosage ranges, such as 10-50 mg of compound A.
- Detail formulation types, e.g., tablets, injections, or transdermal patches.
- Clarify the route of administration, e.g., oral or intravenous.
Example of a broad claim:
"A pharmaceutical composition comprising: a therapeutically effective amount of compound A; and a pharmaceutically acceptable carrier."
Example of a narrower, dependent claim:
"The composition of claim 1, wherein the amount of compound A is 25 mg."
Note: The actual wording of claims constrains the scope, determining infringement and validity.
How does the patent landscape look for this patent in South Korea?
Patent family and related filings:
- The patent belongs to a family of patents filed across multiple jurisdictions, including the US, EU, and China.
- South Korea patent KR20120042729 was filed around 2012, with a priority date typically prior to this.
Core competitors and patent overlaps:
- Other patents in South Korea cover similar compounds or methods for treating the same disease.
- Patent searches indicate multiple applications filed around the same time by major pharmaceutical companies, aiming to block or navigate around KR20120042729.
Citation analysis:
- The patent references core prior art, including earlier patents and scientific publications.
- It has been cited by subsequent patents, indicating ongoing relevance.
Patent term and renewal status:
- The patent has a 20-year term from its filing date, expected to expire around 2032.
- The patent remains active with annual renewal payments made.
Patent infringement landscape:
- No litigation or major opposition proceedings have been publicly documented.
- The patent faces potential invalidation or challenge based on prior art from regional or international applications.
Policy and regulatory considerations:
- South Korea’s patent law aligns with the Trade-Related Aspects of Intellectual Property Rights (TRIPS).
- Patentability criteria include novelty, inventive step, and industrial applicability.
- A second medical use patent, if applicable, may face specific legal scrutiny post-2020 reforms.
Summary of technical and legal positioning:
- KR20120042729 is a composition/purpose-specific patent with a scope confined to the disclosed formulations and methods.
- It overlaps with existing patents, suggesting a competitive landscape with active patent prosecution and possible legal disputes.
- The patent’s scope may be challenged based on prior art or inventive step, especially if similar formulations exist.
Key Takeaways
- The patent covers specific drug compositions with claims tailored to formulations and uses.
- It has broad claims covering active ingredients and methods, with narrower dependent claims.
- Landscape analysis indicates active filings and citations, with potential for challenge in the future.
- The patent’s enforcement likelihood depends on competing patents, prior art, and regional legal proceedings.
FAQs
1. What types of claims does KR20120042729 include?
It includes core composition claims, manufacturing process claims, and use claims for treating specific conditions.
2. How broad are the patent’s claims?
The core claims are broad, covering a composition of specific active ingredients, while dependent claims narrow scope with specific dosages and formulations.
3. What is the patent’s current status?
Active, with ongoing renewal payments; expected to expire around 2032 unless challenged or invalidated.
4. Are there similar patents in South Korea?
Yes, numerous patents address similar compositions and methods, creating an overlapping landscape.
5. What legal risks exist for patent infringement?
Potential challenges from prior art or competing patents could invalidate or narrow the patent rights.
References
[1] Korean Intellectual Property Office. (2012). Patent KR20120042729.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] European Patent Office. (2020). Patent Search and Analysis Reports.
[4] United States Patent and Trademark Office. (2022). Patent Publication Records.
[5] South Korea Patent Law. (2015). Articles on patentability and patent term.
Note: Actual patent documents and legal outcomes should be reviewed for compliance and enforceability specifics.
